Mirror Therapy Combined With Task- vs. Impairment-oriented Rehabilitation Program
Launched by I-SHOU UNIVERSITY · Jun 29, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring new ways to help people recover after having a stroke. Specifically, it’s looking at how mirror therapy—where a person uses a mirror to create the illusion that their affected arm is moving normally—can be combined with different types of rehabilitation programs. Participants will be divided into three groups: one will receive mirror therapy with a focus on daily tasks, another with a focus on overcoming impairments, and the third will receive a combination of both rehabilitation approaches. Each session will last for 90 minutes, three times a week, over a six-week period.
To be eligible for this study, participants should be between 20 and 80 years old and must have had their first stroke at least three months prior. They should also be able to follow instructions and have a certain level of movement ability in their affected arm. However, those with serious health issues or other conditions that could affect their participation will not be included. This trial is not currently recruiting participants, but it aims to provide valuable insights into effective rehabilitation methods for stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. A first-ever unilateral stroke ≥3 months
- • 2. Age between 20 and 80 years
- • 3. Baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score \>10
- • 4. No severe spasticity in any joints of the affected arm
- • 5. Ability to follow the instructions
- • 6. No participation in other studies during the study period
- • 7. Willingness to provide informed written consent.
- Exclusion Criteria:
- • 1. Serious medical problems or poor physical conditions that might be detrimental to study participation.
About I Shou University
i-Shou University is a distinguished academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and research, the university collaborates with various stakeholders to develop and evaluate novel therapeutic interventions. Leveraging its multidisciplinary expertise and state-of-the-art facilities, i-Shou University aims to contribute to the improvement of patient outcomes and the advancement of medical science. The university's focus on ethical standards and rigorous methodologies ensures the integrity and reliability of its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Yi-chun Li, Doctor
Principal Investigator
I-Shou University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported